All Resources

An overview of the screening methods for autoimmune type 1 diabetes (T1D).

An overview of the stages of autoimmune type 1 diabetes, from the development of autoimmunity through to insulin dependence. 

Expert consensus on monitoring individuals with T1D islet autoantibodies: detection, monitoring frequency, and psychosocial support for managing autoimmune T1D.

T1D is an autoimmune disease whereby autoreactive T-cells drive progressive beta-cell damage and destruction, ultimately leading to insulin deficiency, dysglycemia, and hyperglycemia. 

Monitoring people with early-stage autoimmune T1D may reduce the risk of serious complications, such as DKA.

Why and Who: an overview of the key considerations and decisions that inform screening people for islet autoantibodies.

Type 1 diabetes is underpinned by autoimmune activity against insulin-producing beta cells, as explained in this video.

Screening for autoimmune T1D involves testing for autoantibodies that are markers of destruction of insulin-producing beta cells.

The burden associated with a diagnosis of autoimmune T1D can be wide-ranging. This video describes the impact of diagnosis on an individual and their family.